Groeneveld Peter W, Sonnad Seema S, Lee Anee K, Asch David A, Shea Judy E
Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.
J Gen Intern Med. 2006 Jun;21(6):559-63. doi: 10.1111/j.1525-1497.2006.00453.x.
New medical technologies are used at different rates among whites and blacks. This variation may be partially explained by racial differences in patient innovativeness-the propensity of patients to adopt unfamiliar therapies.
To measure how innovativeness varies among patients and how it may influence patients' attitudes toward new medical technologies.
Cross-sectional survey.
Primary care patients (n=171-108 blacks, 63 whites) at an urban Veterans Affairs medical center.
Respondents answered questions about their general innovativeness and innovativeness regarding medical technology, and they responded to a vignette describing either a hypothetical new prescription drug or implantable device.
There were no significant racial differences in general innovativeness, but whites had higher medical technology innovativeness (P=.001). Whites were also more likely to accept the new prescription drug (P=.003), but did not differ from blacks in acceptance of the new implantable device. In multivariate analyses, lower medical technology innovativeness scores among blacks were significantly associated with less favorable reactions to both the prescription drug (P<.001) and the medical device (P<.001). In contrast, although whites with lower medical technology innovativeness were similarly less inclined to accept the new implantable device (P=.02), there was no significant association between medical technology innovativeness and positive attitudes to the new prescription drug among whites.
Blacks and whites have differing attitudes toward medical innovation. These differences are associated with significant racial differences in response to particular health care technologies. These findings suggest potentially remediable causes for racial differences in the utilization of innovative medical technologies.
新的医疗技术在白人和黑人中的使用比例不同。这种差异可能部分归因于患者创新能力的种族差异，即患者采用不熟悉疗法的倾向。
衡量患者的创新能力如何变化，以及它如何影响患者对新医疗技术的态度。
横断面调查。
一家城市退伍军人事务医疗中心的初级保健患者（n = 171，其中108名黑人，63名白人）。
受访者回答了关于他们的总体创新能力和医疗技术创新能力的问题，并对描述一种假设的新处方药或可植入设备的 vignette 做出回应。
总体创新能力方面没有显著的种族差异，但白人在医疗技术创新能力方面更高（P = 0.001）。白人也更有可能接受新处方药（P = 0.003），但在接受新可植入设备方面与黑人没有差异。在多变量分析中，黑人较低的医疗技术创新能力得分与对处方药（P < 0.001）和医疗设备（P < 0.001）的不太积极反应显著相关。相比之下，虽然医疗技术创新能力较低的白人同样不太倾向于接受新可植入设备（P = 0.02），但白人中医疗技术创新能力与对新处方药的积极态度之间没有显著关联。
黑人和白人对医疗创新的态度不同。这些差异与对特定医疗保健技术的反应中的显著种族差异相关。这些发现表明了创新医疗技术使用中种族差异的潜在可补救原因。
